Myelodysplasia after autologous stem cell transplantation for multiple myeloma.

被引：1
|
作者：
Franz, Gregory [1 ]
McClune, Brian [1 ]
Buadi, Francis [1 ]
Walsh, William [1 ]
White, Frank [1 ]
Przepiorka, Donna [1 ]
机构：
[1] UT Blood & Marrow Ttransplant Ctr, Memphis, TN USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
10.1182/blood.V108.11.5329.5329
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5329
引用
收藏
页码：424B / 424B
页数：1
相关论文
共 50 条
  • [21] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 73 - 73
  • [22] Symptom burden after autologous stem cell transplantation for multiple myeloma
    Campagnaro, Erica
    Saliba, Rima
    Giralt, Sergio
    Roden, Linda
    Mendoza, Floralyn
    Aleman, Ana
    Cleeland, Charles
    Weber, Donna
    Brown, Jane
    Anderson, Karen O.
    CANCER, 2008, 112 (07) : 1617 - 1624
  • [23] Long-term outcome of autologous and myeloablative allogeneic stem cell transplantation for Multiple Myeloma.
    Kuruvilla, J
    Nevill, TJ
    Nitta, J
    Le, A
    Forrest, DL
    Lavoie, JC
    Nantel, SH
    Song, KW
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Shepherd, JD
    BLOOD, 2003, 102 (11) : 475A - 475A
  • [24] Individualized high dose busulfan in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Clopés, A
    Sureda, A
    Brunet, S
    Altés, A
    Martino, R
    Paladio, N
    Queraltó, JM
    Mangues, MA
    Sierra, J
    BLOOD, 2001, 98 (11) : 201A - 201A
  • [25] Patient-reported outcomes following autologous stem cell transplantation for patients with multiple myeloma.
    Biran, Noa
    Jensen, Roxanne
    Potosky, Arnold L.
    Siegel, David Samuel DiCapua
    Vesole, David H.
    Mandelblatt, Jeanne S.
    Richter, Joshua Ryan
    McClendon, Trina
    Kuo, Charlene
    Coleman, Claire
    Zotou, Vasiliki
    Li, Shaw
    Alintah, Princess
    McGuire, Colleen
    Rini, Christine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [26] Feasibility of high dose busulfan and melphalan with autologous hematopoietic stem cell transplantation in multiple myeloma.
    Begum, U
    Fitzgerald, D
    Yong, LO
    Grand, M
    Thomas, U
    Chen, Y
    Patel, A
    Goodman, D
    Dillon, C
    Amorosi, E
    Cook, P
    BLOOD, 1997, 90 (10) : 4346 - 4346
  • [27] Hospital in the home (HITH) care following autologous stem cell transplantation for lymphoma and multiple myeloma.
    Johnson, Wendy
    Kerridge, Ian
    Milton, Cathie
    Carr, Debbie
    Enno, Arno
    Bray, Louisa
    Booth, Angela
    AUSTRALIAN JOURNAL OF ADVANCED NURSING, 2006, 23 (04) : 34 - 39
  • [28] Megatherapy and autologous stem cell transplantation in patients with multiple myeloma. The experience of a single haematological clinic
    Papanicolaou, X.
    Maltezas, D.
    Dima, J.
    Dadakaridou, M.
    Hatziantoniou, V.
    Vlamis, C.
    Patos, P.
    Athanasopoulos, A.
    Repousis, P.
    Kotsopoulou, M.
    Megalakaki, A.
    Mitsouli-Mentzikoff, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 191 - 191
  • [29] Double autologous stem cell transplantation with CD34 selected cells for multiple myeloma.
    Nedellec, G
    Ceccaldi, B
    Fagot, T
    Souleau, B
    Traulle, C
    Merrer, J
    De Revel, T
    Joussemet, M
    BONE MARROW TRANSPLANTATION, 1999, 23 : S137 - S137
  • [30] Predictors of blood transfusion requirements in patients undergoing autologous stem cell transplantation for multiple myeloma.
    Pendergrast, Jacob
    Al Farsi, Khalil
    Al-Huneini, Mohammed
    Maliakkal, Maya
    Pond, Gregory
    Chen, Christine
    BLOOD, 2006, 108 (11) : 848A - 848A
12345